Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis in Ulcerative Colitis
NCT00268164Phase 2Terminated
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2004
- Primary completion
- Mar 2007
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 2 trial of lactobacillus acidophilus and bifidobacterium animalis lactis in ulcerative colitis (UC), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Number of patients with relapse at 12 months. Started Jun 2004; status: terminated.
02
Drugs
lactobacillus acidophilusbifidobacterium animalis lactis
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00268164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268164.